Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37357
Title: Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
Authors: Mar A. ;Low Z.M.
Institution: (Low, Mar) Department of Dermatology, Monash Health, Clayton, VIC, Australia
Issue Date: 11-Jun-2018
Copyright year: 2018
Publisher: Blackwell Publishing
Place of publication: Australia
Publication information: Australasian Journal of Dermatology. 59 (2) (pp 131-134), 2018. Date of Publication: May 2018.
Journal: Australasian Journal of Dermatology
Abstract: An increased expression of interleukin-23 has been observed in patients with pyoderma gangrenosum, leading to the use of ustekinumab as a therapeutic option. We report the successful use of ustekinumab in three patients with treatment-resistant pyoderma gangrenosum of varying clinical presentations.Copyright © 2017 The Australasian College of Dermatologists
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/ajd.12744
ORCID: Low, Zhi Mei; ORCID: http://orcid.org/0000-0003-0848-4524
PubMed URL: 29205260 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29205260]
ISSN: 0004-8380
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/37357
Type: Article
Type of Clinical Study or Trial: Case series or case report
Appears in Collections:Articles

Show full item record

Page view(s)

22
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.